Sientra to Report Second Quarter 2020 Financial Results on August 10, 2020

Rhea-AI Summary

Sientra, Inc. (NASDAQ: SIEN) will release its Q2 2020 financial results on August 10, 2020, after market close. A conference call to discuss the results is scheduled for the same day at 4:30 p.m. ET, with dial-in access available for both domestic and international callers. The call will also be webcast live on the company’s Investor Relations website and archived for future access. Sientra continues to enhance its portfolio in the medical aesthetics market, focused on improving patients’ self-esteem and body image.

SANTA BARBARA, Calif., July 27, 2020 (GLOBE NEWSWIRE) -- Sientra, Inc. (NASDAQ: SIEN) (“Sientra” or the “Company”), a diversified medical aesthetics company, today announced that it will release financial results for the second quarter of 2020 after the close of trading on Monday, August 10, 2020. Sientra will host a conference call to discuss financial results the same day at 4:30 p.m. Eastern Time.

The dial-in numbers are 844-464-3933 for domestic callers and 765-507-2612 for international callers. The conference ID is 1379352.

A live webcast of the conference call will be available on the Investor Relations section of the Company's website at www.sientra.com. The webcast will be archived on the website following the completion of the call.

About Sientra
Headquartered in Santa Barbara, California, Sientra is a diversified global medical aesthetics company and a leading partner to aesthetic physicians. The Company offers a suite of products designed to make a difference in patients' lives by enhancing their body image, growing their self-esteem, and restoring their confidence. Sientra has developed a broad portfolio of products with technologically differentiated characteristics, supported by independent laboratory testing and strong clinical trial outcomes. The Company’s Breast Products Segment includes its OPUS® breast implants, the first fifth generation breast implants approved by the FDA for sale in the United States, its ground-breaking Allox2® breast tissue expander with patented dual-port and integral drain technology, and BIOCORNEUM® the #1 performing, preferred and recommended scar gel of plastic surgeons(*). The Company’s miraDry Segment, comprised of its miraDry® system, is approved for sale in over 56 international markets and is the only non-surgical, FDA-cleared device indicated for the permanent reduction of underarm sweat and hair and may also reduce odor.

Sientra uses its investor relations website to publish important information about the Company, including information that may be deemed material to investors. Financial and other information about Sientra is routinely posted and is accessible on the Company’s investor relations website at www.sientra.com.

^(*) Data on file

Contact
Investor Relations
805-679-8885

FAQ

When will Sientra release its Q2 2020 financial results?

Sientra will release its Q2 2020 financial results on August 10, 2020, after the market closes.

What time is the Sientra Q2 2020 earnings call?

The Q2 2020 earnings call will be held on August 10, 2020, at 4:30 p.m. Eastern Time.

How can I access the Sientra earnings call?

You can access the earnings call by dialing 844-464-3933 for domestic calls or 765-507-2612 for international calls, using conference ID 1379352.

Will there be a webcast for Sientra’s earnings call?

Yes, a live webcast of the earnings call will be available on Sientra's Investor Relations website.

What products does Sientra offer?

Sientra offers products for medical aesthetics, including OPUS® breast implants and the miraDry® system for underarm sweat reduction.